investor login

contact

team

dedicated funds

news

 portfolio

Synaptrix is developing a first-in-kind, drug-free neuromodulation therapy for post-operative pain that uses targeted electrical stimulation to selectively block pain signals while preserving motor function. Its NOVABLOCâ„¢ system is designed to provide weeks of pain relief from a single treatment, reducing or eliminating the need for opioids following surgery.

Active, CRV, HVP VII, Med Tech, Portfolio

back to portfolio

contact

© hatteras venture partners | all rights reserved | terms + privacy | site credit

 team

 portfolio

news

home

Hatteras Venture Partners is a venture capital firm that builds transformational companies in areas of health innovation.

dedicated funds

contact

 team

dedicated funds

news

home

 portfolio